Studies have shown that GLP-1 receptor agonists are effective for preventing or managing obesity
Stahl EP, Dhindsa DS, Lee SK, Sandesara PB, Chalasani NP, Sperling LS (2019) Nonalcoholic fatty liver disease and the heart: JACC state-of-the-art review
Lucentis, by Genentech, is indicated for the treatment of wet AMD, macular edema following RVO, DME, diabetic retinopathy and myopic choroidal neovascularization
IGF-1 LR3 remains an agonist of the IGF-1 receptor, but it has very low affinity for IGFBPs, which inhibit IGF-1, making it more potent
I love that this supplement is RDN-formulated and customers get access to a RDN, however, this supplement might be a waste of your money